Gold Nanoparticles Market Forecasts to 2030 - Global Analysis By Type, Application, End User and by Geography

According to Stratistics MRC, the Global Gold Nanoparticles Market is accounted for $3.81 billion in 2023 and is expected to reach $9.89 billion by 2030 growing at a CAGR of 14.6% during the forecast period. Gold nanoparticles are a versatile and widely studied nanomaterial, with typical sizes ranging from 1 to 100 nanometers. Their unique optical characteristics, such as their size- and shape-dependent vivid colors, make them useful for imaging, medication delivery, and medical diagnostics. Due to their biocompatibility, which enables targeted treatments and biosensors, these nanoparticles are highly valued.

According to American Society for Testing and Materials (ASTM international 2006), nanoparticles are those particles which have two or more than two dimensions and are in the size range of 1 - 100 nm.

Market Dynamics:

Driver:

Growing Concerns about the Environment

Gold nanoparticles are becoming more popular as environmental concerns-such as air and water pollution-get bigger. They are used in a number of environmental applications, including air pollution monitoring and water purification. Moreover, the ability of gold nanoparticles to catalyze the breakdown of pollutants and their application in environmental toxin detection sensors are in line with the global focus on environmental protection and sustainability.

Restraint:

High production expenses

The cost of raw materials, energy usage, and the difficulty of synthesis techniques are some of the variables that affect the cost of producing gold nanoparticles. Higher production costs result from the need for precise control over size and shape in specialized applications. Furthermore, it can be difficult to achieve economies of scale because it can be technically difficult to maintain consistency in quality and size distribution at higher volumes. Their adoption in cost-sensitive industries and applications may be restricted by this cost factor.

Opportunity:

Developments in medicine

There are a lot of opportunities in the field of medicine with gold nanoparticles. Their special qualities can be used to deliver drugs with precision and fewer side effects by allowing for targeted delivery. They are also useful instruments for early illness diagnosis and detection, particularly in the diagnosis of infectious diseases and cancer. Additionally, gold nanoparticles have the potential to completely transform healthcare as medical research progresses by increasing treatment efficacy and diagnostic precision.

Threat:

Rivalry with different nanomaterials

One major competitive threat to gold nanoparticles is the development of substitute nanomaterials with comparable or better properties but at a lower price. Moreover, materials like quantum dots, silver nanoparticles, and carbon-based nanomaterials can change consumer demand, which forces businesses to keep coming up with new ideas and showcasing the special benefits of gold nanoparticles.

COVID-19 Impact:

The market for gold nanoparticles has been affected by the COVID-19 pandemic in many ways. On the one hand, the market was growing due to the increase in demand for gold nanoparticles in medical and diagnostic applications, such as vaccine delivery and diagnostics. The market for gold nanoparticles is anticipated to expand after the pandemic passes, especially in the environmental and healthcare industries. However, caution should be exercised regarding supply chain weaknesses and economic unpredictability.

The Drug Delivery segment is expected to be the largest during the forecast period

The drug delivery segment is anticipated to hold the largest share in the market. The special qualities of gold nanoparticles have made them very popular in drug delivery applications. Therapeutic agents can be precisely delivered to particular cells or tissues by engineering these nanoparticles. It is possible to functionalize the surface of gold nanoparticles to improve their biocompatibility and lengthen their bloodstream circulation. Furthermore, they can be customized to meet specific therapeutic needs thanks to their adjustable size and shape.

The Biotechnology Companies segment is expected to have the highest CAGR during the forecast period

In the market for gold nanoparticles, the segment with the highest CAGR is biotechnology companies. Gold nanoparticles are becoming more and more popular in biotechnology applications such as drug delivery, imaging, diagnostics, and therapeutics. Gold nanoparticles are ideal for use in biomedical applications because of their special optical, thermal, and electrical characteristics. Moreover, the potential of gold nanoparticles in targeted drug delivery and imaging can be further enhanced by functionalizing them with particular ligands and biomolecules.

Region with largest share:

North America, which includes both the United States and Canada, holds the largest share of the market for gold nanoparticles. Due to the region's intense research and development efforts in material science, healthcare, and nanotechnology, it has a strong market presence. Moreover, the demand for gold nanoparticles has grown significantly, in large part due to the efforts of research institutions, pharmaceutical companies, and biotechnology firms in North America.

Region with highest CAGR:

In the market for gold nanoparticles, the European region is anticipated to have the highest CAGR. Additionally, gold nanoparticles find wide-ranging applications in imaging, drug delivery, and diagnostics; these developments in healthcare and biotechnology research are the source of this noteworthy growth. With its strong support for nanotechnology research and its dedication to innovation, Europe is well-positioned to lead the way in propelling market expansion.

Key players in the market

Some of the key players in Gold Nanoparticles market include: NanoComposix , Agilent Technologies Inc., Expedeon Ltd., BBI Solutions, NanoHybrids Inc, Meliorum Technologies Inc, Cline Scientific, Nanopartz Inc, Goldsol Inc, Abcam plc, Merck Group, Cytodiagnostics Inc, Nanosphere Inc, Metalor Technologies International, Solaris Nanosciences Corporation , Sigma-Aldrich , Tanaka Holdings Co., Ltd, Sona Nanotech Inc and Strem Chemicals Inc.

Key Developments:

In October2023, TANAKA, a core company of the TANAKA Precious Metals Group, has developed a high-entropy alloy powder composed entirely of precious metals with a fine particle size of 10um or less, high crystallinity and excellent composition uniformity. This is the world's first high-entropy alloy powder composed entirely of five precious metals: platinum, palladium, iridium, ruthenium, and rhodium. TANAKA has established a mass production process and will provide samples in October.

In March 2023, Agilent Technologies Inc. announced a multi-year distribution agreement with Proscia, a leader in digital pathology to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia's Concentriq Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.

In May 2020, NanoComposix has established a partnership with Amplicon Biotech to expand access for customers across India to the suite of products and services offered by nanoComposix, a manufacturer of a variety of nanoparticle products for use in lateral flow assays, drug delivery, anti-microbials, optical displays, among other applications.

Types Covered:

• Gold Nanoparticle-Based Drug Delivery Systems
• Pegylated Gold Nanoparticles
• Gold Nanoshells
• Gold Nanoparticle-Based Contrast Agents
• Other Types

Applications Covered:

• Sensors
• Photothermal Therapy
• Electronics
• Wound Healing
• Cosmetics
• Nanofluids
• Food Industry
• Textiles
• Water Purification
• Drug Delivery
• Other Applications

End Users Covered:

• Pharmaceutical Companies
• Hospitals and Clinics
• Research Institutions
• Biotechnology Companies
• Dental Clinics
• Veterinary Clinics
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances